1-5 of 5
Hsiang-Chun Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models

Natalia Baran, PhD MD, Lina Han, PhD, Shannon Renee Sweeney, MS, Alessia Lodi, PhD, Shelley Herbrich, MS, Antonio Cavazos, MSc, Helen Ma, MS, Jason P Gay, MS, Ningping Feng, PhD, Hsiang-Chun Chen, PhD, Marcin Kaminski, PhD, Kenneth Dunner, Jr., AS, BS, Guilin Tang, MD, Gheath Alatrash, DO, PhD, Jennifer Molina, PhD, Monica L. Guzman, PhD, Jing Ning, PhD, Stefano Tiziani, PhD, Joseph R Marszalek, PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1350.
https://doi.org/10.1182/blood.V130.Suppl_1.1350.1350
Published: 2017
Journal Articles

Standardized Targeted Sequencing of 29 Genes with Recurrent Mutations in Chronic Lymphocytic Leukemia (CLL) Helps to Better Define Clinical Correlates and Genomic Hotspots

Boyu Hu, MD, Keyur Patel, MD PhD, Xuemei Wang, Hsiang-Chun Chen, PhD, Philip A Thompson, MBBS, Michael J. Keating, MD, Jan A. Burger, MD PhD, Nitin Jain, MD, Alessandra Ferrajoli, MD, Prithviraj Bose, MD, Zeev Estrov, MD, Raja Luthra, Mark Routbort, MD PhD, Rashmi Kanagal-Shamanna, MD, L. Jeffrey Medeiros, MD, C. Cameron Yin, MD PhD, Zhuang Zuo, Chi Young Ok, MD, Sanam Loghavi, MD, William G Wierda, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4304.
https://doi.org/10.1182/blood.V130.Suppl_1.4304.4304
Published: 2017
Journal Articles

Archetypes of AML Defined Using Whole Exome Sequencing and Clinical Characteristics in a Diverse Group of Patients

Christopher B. Benton, MD, Koichi Takahashi, MD, Prithviraj Bose, MD, Feng Wang, PhD, Hsiang-Chun Chen, Xiaofeng Zheng, Jianhua Zhang, Xuemei Wang, MS, Xiaoping Su, PhD, Guillermo Montalban-Bravo, MD, Ghayas C. Issa, MD, Naval Daver, MD, Elias J. Jabbour, MD, Courtney D DiNardo, MD, Carlos E Bueso-Ramos, MD PhD, Keyur Patel, MD, Steven M. Kornblau, MD, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Jorge E. Cortes, MD, Farhad Ravandi, MD, Michael Andreeff, MD PhD, Guillermo Garcia-Manero, MD, Andrew Futreal, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 597.
https://doi.org/10.1182/blood.V128.22.597.597
Published: 2016
Journal Articles

A Phase II Clinical Trial of Azacitidine and Vorinostat for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) with Poor Performance Status, Comorbidities, Other Active Malignancies or Organ Dysfunction Not Eligible for Conventional Clinical Trials

Guillermo Montalban-Bravo, MD, Xuelin Huang, PhD, Elias J. Jabbour, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD MSCE, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Srdan Verstovsek, MD PhD, Tapan M. Kadia, MD, Naval G. Daver, MD, William G. Wierda, MD PhD, Yesid Alvarado, MD, Marina Konopleva, MD PhD, Farhad Ravandi, MD, Zeev Estrov, MD, Nitin Jain, MD, Ana Alfonso Pierola, MD PhD, Mark Brandt, BS, Troy Sneed, Hsiang-Chun Chen, Hui Yang, MD PhD, Carlos E Bueso-Ramos, MD PhD, Sherry Pierce, BSN, BA, Elihu H. Estey, MD, Zachary S. Bohannan, MA, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 1999.
https://doi.org/10.1182/blood.V128.22.1999.1999
Published: 2016
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in First Remission Improves Outcome Irrespective of FLT3-ITD Allelic Burden Among Patients with Acute Myeloid Leukemia and FLT3-ITD Mutation

Betul Oran, MD, Richard E. Champlin, Jorge E. Cortes, Marcos de Lima, MD, Xuemei Wang, PhD, Hsiang-Chun Chen, Farhad Ravandi, MD, Stefan O. Ciurea, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD
Journal: Blood
Blood (2014) 124 (21): 2531.
https://doi.org/10.1182/blood.V124.21.2531.2531
Published: 2014